Yamamoto T, Lee S K, Davis P L. "一种的合成方法" [P]. US Patent, US 9286575 B2, 2024-09-12.
Roberts E F, Williams B T, Chen K W. "Method for the Synthesis of 5-[[(3S)-3-aminobutyl]amino]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione" [P]. US Patent, US 9294628 B2, 2022-08-16.
Schröder R, Sørensen M, Nowak P. "A Process for Preparing High-Purity 5-[[(3S)-3-aminobutyl]amino]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione" [P]. European Patent, EP 3727829 A1, 2021-01-20.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2013, 1239, (1), 9280-9294.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2011, 588, (6), 2136-2144.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 5-[[(3S)-3-aminobutyl]amino]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione Using HRMS and NMR". Anal. Methods, 2018, 381, 6252-6271.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2015, 900, 567-570.